ARTICLE | Clinical News
Ruconest conestat alfa regulatory update
April 25, 2016 7:00 AM UTC
The European Commission approved an expanded label for Ruconest conestat alfa from Pharming to treat acute angioedema attacks to include adolescents with hereditary angioedema (HAE) due to complement...